BeOne Medicines (ONC) Other Gross PP&E Adjustments (2016 - 2026)

BeOne Medicines (ONC) has 11 years of Other Gross PP&E Adjustments data on file, last reported at $1.8 billion in Q1 2026.

• On a quarterly basis, Other Gross PP&E Adjustments rose 156.28% year-over-year to $1.8 billion in Q1 2026; TTM through Mar 2026 was $1.8 billion, a 156.28% increase from a year earlier, with the FY2025 full-year figure at $1.8 billion, up 233.45% from the prior year.
• Other Gross PP&E Adjustments for Q1 2026 stood at $1.8 billion, up from $1.8 billion in the prior quarter.
• Over the last five years, Other Gross PP&E Adjustments for ONC reached as high as $1.8 billion in Q1 2026 and fell as low as -$24.9 million in Q2 2024.
• Historically, Other Gross PP&E Adjustments has averaged $598.8 million across 5 years, with a median of $339.4 million in 2022.
• On a YoY basis, Other Gross PP&E Adjustments climbed as much as 17364.18% in 2024 and fell as far as 115.04% in 2024.
• Year by year, Other Gross PP&E Adjustments stood at $320.2 million in 2022, then tumbled by 100.96% to -$3.1 million in 2023, then soared by 17364.18% to $530.2 million in 2024, then soared by 233.45% to $1.8 billion in 2025, then advanced by 1.49% to $1.8 billion in 2026.
• Per Business Quant data, the three most recent Other Gross PP&E Adjustments figures were $1.8 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.7 billion in Q3 2025.